Andrea Abbott to Combined Modality Therapy
This is a "connection" page, showing publications Andrea Abbott has written about Combined Modality Therapy.
Connection Strength
0.049
-
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention. Breast Cancer Res Treat. 2019 Feb; 173(3):559-571.
Score: 0.031
-
Severe electrolyte disturbances after hyperthermic intraperitoneal chemotherapy: oxaliplatin versus mitomycin C. Ann Surg Oncol. 2011 Jan; 18(1):174-80.
Score: 0.018